on putative therapeutic targets for this group of patients.
Upregulation of Gingival Tissue miR-200b in Obese Periodontitis Subjects CLiniCAL inVESTiGATiOnS
Abstract: Increased local immune and inflammatory responses in obese individuals with periodontitis may explain the aggressive clinical presentation and altered treatment response when compared to that of normal weight subjects. Our goal was to identify any differences in microRNA (miRNA) expression profiles of gingival tissue in periodontitis when obesity is present, which may suggest novel molecular pathways that this miRNA network may affect. Total RNA was extracted from gingival tissue biopsies collected from normal weight and obese individuals with periodontitis; miRNA expression profiling was performed with Affymetrix GeneChip miRNA 3.0 arrays; and results were validated with quantitative reverse transcription polymerase chain reaction (qRT-PCR) . In silico identification of previously confirmed miRNA gene targets was conducted through miRTarBase and miRWalk databases, and pathway enrichment analysis identified enriched miRNA gene sets. Expression of selected genes in the same biopsy samples was tested with qRT-PCR. The gingival tissue miRNA profile of obese patients, compared to that of normal weight patients, showed 13 upregulated and 22 downregulated miRNAs, among which miR-200b was validated by qRT-PCR to be significantly increased in obesity. Functional analysis of 51 experimentally validated miR-200b gene targets identified enrichment of genes involved in cell motility, differentiation, DNA binding, response to stimulus, and vasculature development pathways not previously identified in the obesityspecific disease profile. Furthermore, the expression of the miR-200b gene targets ZEB1/2, GATA2, and KDR was confirmed by qRT-PCR as being lower in obese patients with periodontitis versus normal weight patients, suggesting a role of miR-200b in regulation of a set of gene targets and biological pathways relevant to wound healing and angiogenesis. Functional studies to explore the role of miR-200b in the above processes may offer new insights Introduction Periodontitis is a chronic polymicrobial oral disease presenting with dysregulated immune and inflammatory responses at the level of connective tissue and bone support surrounding the teeth, leading to tooth loss if left untreated (Kornman and Van Dyke 2008; Nahid et al. 2011) . Obesity is associated with a higher prevalence of periodontitis where adipocytes surpass their lipid storage role and exert a number of endocrine functions, resulting in a state of lowgrade inflammation and insulin resistance (Suvan et al. 2011) . This may explain the more severe clinical presentation of periodontitis before treatment and poor response to periodontal therapy with less pocket resolution and higher bleeding levels (Suvan et al. 2014) . In obesity, factors such a hyperglycemic status, the presence of advanced glycation end products, modifications of saliva's pH, and neutrophil dysfunction amplify the immune stress and affect the biological phenotype of periodontitis (Boesing et al. 2009 ).
MicroRNAs (miRNAs) are small (20to 24-nucleotide) noncoding RNAs that mediate translational inhibition or degradation, by binding most commonly at the 3′ UTR of their messenger RNA (mRNA) targets (Bartel 2009 ). The latest miRBase release (v. 21, June 2014) contains 2,588 human mature miRNAs, estimated to regulate 20% to 30% of protein-coding genes. Microarray and polymerase chain reaction (PCR) array analyses have identified a number of differentially expressed miRNAs in individuals with periodontitis compared to healthy controls (Xie et al. 2011; Perri et al. 2012) . Studies using experimental animal models of periodontitis have confirmed the overexpression of miR-146a in maxillary biopsies, coupled with increased expression of inflammatory cytokines (Nahid et al. 2011) . A comprehensive screening of periodontitisaffected gingiva (Stoecklin-Wasmer et al. 2012 ) identified a specific miRNA profile and examined the mRNA expression of predicted targets in a transcriptomic dataset. Obese individuals were included only in 1 of these profiling studies, which used a selective miRNA array and a limited number of obese individuals (n = 5) with periodontitis (Perri et al. 2012) . miRNAs regulate gene expression by providing negative feedback in a broad array of cellular processes that occur in periodontitis and that may be affected by obesity. Therefore, we hypothesized that obese periodontitis patients present with a different miRNA profile than that of normal weight patients with periodontitis and that some of these miRNAs would be associated with novel gene targets involved in the disease pathology. Using an Affymetrix miRNA microarray, quantitative reverse transcription PCR (qRT-PCR), and bioinformatics techniques we identified novel miRNA-regulated molecular processes that may contribute to an aggravated pathogenesis of periodontitis in obesity.
Materials and Methods
For full version of the methods, see Appendix.
Study Participant Selection and Sample Collection
A flowchart of the study design is presented in Appendix Figure 1 . Thirtysix eligible individuals were identified among participants of a larger ongoing trial within the Unit of Periodontology, UCL Eastman Dental Institute and Hospital. All participants gave informed consent to participate in the study, which was approved by the Surrey Borders Research Ethics Committee, London (09/H0806/43). The investigators were blinded to group allocation until all laboratory work was concluded. Participants were classified as normal weight (body mass index, 20-24.9 kg/m 2 ) or obese (≥30 kg/m 2 ), according to the World Health Organization (2012) classification for defining body composition. All recruited subjects were required to have severe periodontitis (probing pocket depths >5 mm and marginal alveolar bone loss >30% with >50% of the teeth affected; Suvan et al. 2014 ) and >15 natural teeth, to be older than 35 y of age, and to be in good general health, free of diabetes or any systemic infection or disease. They were excluded if they were on chronic antibiotic (≥2 wk), anti-inflammatory, or anticoagulant therapy during the month preceding the baseline exam. Details of the additional inclusion and exclusion criteria are provided in Appendix Table 1 . A gingival excess tissue sample was collected from each individual during the nonsurgical therapy phase and maintained in RNAlater solution (Life Technologies, Carlsbad, CA, USA) at -20°C until further analysis.
RNA Isolation
Total RNA was isolated with the mirVana miRNA Isolation Kit (Ambion). Assessment of sample quality was performed with the Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA), and only 10 samples of the best RNA integrity (estimated as RNA integrity number, 8.65 ± 0.21) were selected for subsequent analyses (due to limited resources available for the GeneChip set of assays). The smaller group of patients shared similar characteristics with the larger group (that contained it), which was included in subsequent analyses.
GeneChip miRNA Microarray Analysis
The FlashTag Biotin RNA Labeling Kit (Genisphere, Hatfield, PA, USA) for Affymetrix GeneChip miRNA Arrays was used to label 500 ng of total RNA by the addition of polyA-polymerase. Samples were hybridized on Affymetrix GeneChip miRNA 3.0 arrays (Affymetrix, Santa Clara, CA, USA) composed of 179,217 probes representing 19,913 mature miRNAs, of which 1,733 are human. The Affymetrix Fluidics protocol (FS450_0003) was followed for hybridization, washing, and scanning of the slides with the GeneChip Scanner 3000. The Affymetrix miRNA QC tools were used for data normalization and background correction. Data analysis was done with Partek 6.6 software (St. Louis, MO, USA) and the fold change level set to 1.2, which was in agreement with previous miRNA microarray studies based on similar size platforms and number of samples (Dalman et al. 2012; Pritchard et al. 2012 ).
qRT-PCR Analysis of miRNA Expression
We used qRT-PCR to validate the expression levels of 6 selected miRNAs from the GeneChip miRNA microarray data that had the highest fold change or the lowest P value between the 2 groups, according to single TaqMan MicroRNA expression assays (Life Technologies) testing all available samples (normal weight, n = 17; obese, n = 19). TaqMan Assay IDs with primer information from manufacturer are presented in Appendix Table 2 .
Bioinformatics Analysis for miR-200b-5p Gene Targets
Bioinformatics analysis was conducted exclusively for miR-200b-5p, the only confirmed target by qRT-PCR. Experimentally validated gene targets for miR-200b were identified in 2 databases: miRWalk (Dweep et al. 2011) and miRTarBase (Hsu et al. 2011) . We combined these gene lists and confirmed the curated interactions (direct miRNA-mRNA binding confirmed by strong experimental evidence) by accessing the published manuscripts.
Functional Enrichment Analysis of miR-200b Targets
The g:profiler functional enrichment tool g:GOSt (http://biit.cs.ut.ee/gprofiler/index .cgi; Reimand et al. 2011 ) was used to look for overrepresentation of Gene Ontology terms in the miR-200b gene targets list relative to the whole human proteome. and pathways was measured with TaqMan gene expression assays (Life Technologies) in all RNA samples that miR-200b-5p was previously measured. The "shortlisted" miR-200b gene targets were ZEB1, ZEB2, CDH1, GATA2, PLCG1, KDR, and UBC (normalization control), as well as SMAD3, which has been reported to regulate miR-200b (Ahn et al. 2012) .
Statistical Analysis
Data from microarray were analyzed with Partek 6.6 and 1-way analysis of variance, and qRT-PCR expression data were analyzed in the R-statistical environment. Differences between obese and normal weight groups were analyzed through a nonparametric test (Mann-Whitney U test) and results were presented as median ± interquartile range. Log transformation normalized the distributions and improved visualization and interpretation of results. The correlation between miR-200b-5p and the combined group of target genes was analyzed by calculating partial correlation coefficients, after removing the effects of obesity. For all analyses, P < 0.05 was considered significant.
Results

Study Demographics
The mean body mass index of the obese group was 36 kg/m 2 , as compared to 22.36 kg/m 2 for the normal weight group. There were no statistically significant differences in age, sex, or ethnicity between the 2 groups, as presented in Appendix Table 3 .
miRNA Expression Profiles of Gingival Tissue by Microarray Expression Analysis
Principal component analysis (PCA) did not show any set of miRNAs clustering in a distinct manner in any group (mapping percentage of 29.9%; Appendix Fig.  2 ). Moreover, a hierarchical clustering analysis resulted in segregation of samples into 2 distinct groups (obese and normal weight; Fig. 1 ). After normalization and using low stringency parameters (fold change ≥1.2 or ≤-1.2; P ≤ 0.05), we detected 13 upregulated and 22 downregulated mature human miRNAs in obese individuals with periodontitis compared to normal weight (Table 1) , with only 3 downregulated miRNAs exceeding a 1.5-fold expression difference (miR-4721, miR-557, miR-4327; fold changes: 1.55, 1.53, 1.50, respectively) ( Table 1 ). The volcano plot depicts these miRNAs in Appendix Figure 3 . The control miRNA RNU6B was not differentially expressed in the study tissues, which confirmed that it is a suitable normalization control for qRT-PCR experiments.
Validation of Microarray miRNA Expression Profiles by qRT-PCR
A total of 6 miRNAs-3 upregulated (miR-323a-3p, miR-200b-5p, miR-188-5p) and 3 downregulated (miR-4721, miR-557, miR-196a)-were selected for validation experiments with qRT-PCR. As highlighted in Table 1 , these were based on criteria such as the greatest fold change (miR-4721 and miR-557 from the downregulated group; miR-188-5p from upregulated group) and lowest P value (miR-323-3p and miR-200b-5p from upregulated group; miR-196a from downregulated group). Using TaqMan MicroRNA expression assays, we measured the expression of these miRNAs using U6snoRNA and RNU6B as endogenous controls (Fig. 2) . As distribution was not normal, data was log transformed to improve interpretation. In all qRT-PCR experiments independent of exclusion of outliers, miR-200b-5p was expressed in significantly higher levels in gingival tissue biopsies from obese patients (64.2% increase in obese patients; P = 0.007). However, qRT-PCR expression of miR-557 and miR-4721 (previously downregulated in obesity in microarray) appeared significantly increased (P = 0.002 and 0.05, respectively). The expression of miR-196a (downregulated in obesity in microarray) and miR-188-5p and miR-323-3p (upregulated in obesity in Unsupervised hierarchical cluster analysis diagram of the differentially expressed microRNAs (miRNAs) in normal weight versus obese individuals with periodontitis. The heatmap highlights miRNA expression (colored grid) linked by a dendrogram (a tree diagram) to hierarchically cluster miRNAs. Each row represents individual human miRNAs, and each column represents a different sample. Each cell is colored according to the level of expression of that gene in that sample. Downregulated miRNAs are illustrated in blue and upregulated in red. A distinct miRNA expression pattern is presented for the normal weight group (left side) and the obese (right side). Earlier naming convention used the miR/miR* nomenclature to identify the mature miRNA that was predominantly expressed from a precursor stem loop. This nomenclature has been replaced with -5p/-3p in miRBase. The miRandola database (http://atlas.dmi.unict.it/mirandola/tools.php; Russo et al. 2012 ) identified the most current name for each miRNA included in our Affymetrix array that did not have an updated nomenclature. miRNA, microRNA. a miRNAs selected to be validated with quantitative reverse transcription polymerase chain reaction because they had the highest fold changes between groups. b miRNAs selected to be validated with quantitative reverse transcription polymerase chain reaction because they had the lowest P values in the comparison of the observed differences. c Furthermore, MiRBase (http://www.mirbase.org) noted that the sequence annotated as miR-720 is likely to be a fragment of a tRNA and so was removed from the database. microarray) were not statistically different between the 2 groups (P = 0.75, 0.3, 0.28, respectively), although they followed the trend of changes observed in the microarray.
In Silico miR-200b Gene Target Identification
We used 2 databases to identify likely gene targets of the validated miRNAs. The target analysis was performed exclusively for the primary transcript of miR-200b-5p (as explained in detail in the Methods section [in the Appendix] and in Appendix Fig. 4 ). The miRWalk database included 203 entries for experimentally validated miR-200b targets. Filtering this list to remove indirect or falsely curated targets identified 62 entries of direct and true interactions, which included 23 unique gene targets (Appendix Table 4 ). To confirm these targets, we used the miRTarBase algorithm, which identified 39 manually curated and experimentally validated unique gene targets (Appendix Table 4 ), of which 11 genes were also curated by miRWalk; these combined approaches provided 51 experimentally validated unique miR-200b gene targets.
Functional Annotation Analysis of miR-200b Gene Targets Using Gene Ontology
We performed a functional enrichment analysis on the 51 validated miR-200b gene targets, using the Gene Ontology dataset (Ashburner et al. 2000) , to understand the biological processes and molecular functions that these genes were associated with. The complete enriched Gene Ontology terms for the above miR-200b targets, along with their statistical significance, are presented in Appendix Table 5 (summarized version in Table 2 ). All the genes included in the analysis had at least 1 annotation within the 3 Gene Ontology domains of "biological process," "molecular function," and "cellular component."
The 51 miR-200b gene targets were enriched for many Gene Ontology processes and suggested that many of these gene targets have roles in "cell differentiation" (24 genes), specifically "epithelial cell differentiation" (9 genes) and "stem cell differentiation" (7 genes), "angiogenesis" (11 genes), "epithelial cell migration" (6 genes), "immune system process" (18 genes), "transcription" (19 genes), "cellular response to stimulus" (33 genes), and "signaling" (32 genes; Table 2 and Appendix Table  5 ). Interestingly, our Gene Ontology analysis predicted involvement of pathways relevant to cell motility, cell differentiation, cell response to stimulus, A selection of enriched Gene Ontology (GO) terms identified by functional analysis through g:profiler for the 51 validated gene targets extracted from the miRWalk and miRTarBase databases. Based on the g:SCS statistical method, a P < 0.05 was considered significant. Bold font highlights the genes that were selected to measure their mRNA expression in our gingival tissue samples. An extended version of this GO analysis summary table is presented in the Appendix Table 5 . T, the number of human genes associated with the GO term; Q, the number of genes analyzed (query dataset); Q&T, the number of genes in the query dataset that are also associated with the GO term (common genes); Q&T/Q, an index of recall; Q&T/T, an index of precision. and tissue development not identified before as possible pathways in an obesity-specific disease profile.
mRNA Expression of miR-200b Gene Targets in Gingival Tissue Biopsies
After outlier exclusion, statistical analysis showed a significant negative correlation between the expression of miR-200b-5p and transcription factors ZEB2 and GATA2 in human gingival tissue biopsies from obese patients with periodontitis ( Fig. 3b : r = -0.46, P = 0.008; Fig. 3d : r = -0.42, P = 0.02, respectively). The same inverse correlation trend toward significance was observed for miR-200b-5p expression and genes ZEB1 and KDR in the same samples from obese patients (Fig. 3a : r = -0.34, P = 0.06; Fig. 3d : r = -0.33, P = 0.06, respectively). The correlation for the combined groups is presented in Appendix Table 6 . Expression of SMAD3 was not significantly correlated with changes in miR-200b-5p expression (P = 0.14), nor was expression levels of E-cadherin (P = 0.89), a known downstream target of ZEB1/2. PLCG1 expression in our gingival tissue samples in both groups was too low to allow comparisons. These findings suggest that the correlation between increased expression of miR-200b-5p and periodontitis in obesity is closely related to the miR-200b-5p regulation of ZEB1/2, GATA2, and KDR genes in these periodontitis patient specimens.
Discussion
In the present study, microarray miRNA profiling of gingival tissue samples revealed a differential miRNA expression in obese individuals with periodontitis when compared to normal weight. Among the 13 upregulated miRNAs and 22 downregulated miRNAs in the presence of obesity, miR-200b-5p expression was found to be 1.6 times higher in obese patients, as replicated with qRT-PCR. We further showed an inverse correlation between miR-200b-5p expression and mRNA expression of its target genes ZEB1, ZEB2, GATA2, and KDR in gingival tissue biopsies from periodontal disease patients, with ZEB2 and GATA2 being statistically significant and ZEB1 and KDR approaching a substantial trend toward significance. Previous studies have demonstrated that miRNA-200b interacts directly with the 3′ UTR of these genes and regulates their expression at the translational level (Ahn et al. 2012) . The above genes play central roles in pathways involved in re-epithelialization of gingival wounds (Tomikawa et al. 2012) , which is an important process in periodontal regeneration and reestablishment of tissue integrity, affecting treatment outcome. miR-200b is expressed in a variety of cells and modulates key cellular functions, such as cell proliferation, motility, apoptosis, and stem cell properties, and it controls signals in angiogenesis and epithelial-mesenchymal transition, a process in which epithelial cells acquire mesenchymal characteristics (Brabletz and Brabletz 2010) . Regulation of miR-200b/c modifies TLR4 signaling in macrophages, with effects on host innate defenses against periodontal pathogens (Wendlandt et al. 2012) , while miR-200c-5p was found to be increased Figure 3 . Inverse correlation between the miR-200b-5p expression and its target genes ZEB1, ZEB2, KDR, and GATA2 in gingival tissue biopsies. (b, d) There was a statistically significant correlation between the expression of miRNA-200b and ZEB2 (r = -0.46, P = 0.008) and between miR-200b-5p and GATA2 (r = -0.42, P = .02). (a, c) The correlations between miR-200b-5p expression and ZEB1 and KDR followed the same trend (r = -0.34, P = 0.06; r = -0.33, P = 0.06, respectively) but did not reach statistical significance.
in inflammatory bowel disease patients (Paraskevi et al. 2012 ). There have been no studies reporting miR-200b expression in gingival tissue in obesity. However, in experimental models of obesity, dietinduced liver injury was correlated with increased miR-200b levels in mouse plasma (Tryndyak et al. 2012 ) and in mouse and rat liver tissue (Alisi et al. 2011; Tryndyak et al. 2012) . Decreased miR-200b expression was reported in obese mouse adipose tissue (Oger et al. 2014 ), suggesting a cell-specific regulation of its expression. One of the known factors regulating hepatic miR-200b expression (Hu et al. 2012) , as well as the regenerative capacity of periodontium (Nokhbehsaim et al. 2014) , is the metabolic hormone leptin, which was not measured in our subjects. In obese patients, gingival miR-200b upregulation could affect reprogramming epithelial-mesenchymal transition (Korpal et al. 2008) , and stem cell pluripotency (Miyazaki et al. 2012 ) is highly relevant to regenerative biological pathways that occur in periodontitis. Since ZEB1 3′ UTR con tains 5 highly conserved miR-200b binding sites and the ZEB2 3′ UTR contains 6 (Gregory et al. 2008; Brabletz and Brabletz 2010) , the suppression of gingival ZEB1/2 expression in the obese biopsies is expected. As ZEB factors are strong epithelial-mesenchymal transition inducers, in obese patients miR-200b overexpression could hinder mesenchymal cell growth over the epithelium and reduce periodontal healing. Furthermore, the association of ZEB2 with the TGFβ/BMP/Wnt pathway (Gregory et al. 2008; Shin et al. 2012; Cong et al. 2013 ) makes it a particularly important factor for the reestablishment of periodontal attachment, as downregulation of Wnt signaling leads to a pathologic widening of the periodontal ligament space (Lim, Liu, Cheng, et al. 2014) and to root resorption (Lim, Liu, Hunter, et al. 2014) . Both ZEB1 and ZEB2 bind to E-boxes in the E-cadherin promoter and control its expression (Ahn et al. 2012 ). Contrary to our expectations, the expression of E-cadherin in the obese gingival biopsies was similar to normal weight. However, a miR-200b effect on other ZEB1-and ZEB2-mediated junctional proteins cannot be excluded (Howe et al. 2011) .
Angiogenesis plays a pivotal role in periodontitis, as it facilitates transporting oxygen and nutrients to the injury site and removal of the cellular debris from the inflamed tissue (Artese et al. 2010) . Downregulation of endothelial miR-200b enables upregulation of GATA2 transcription factor activity, which regulates the promoters of many endothelial genes, and thus, successful angiogenic outcome (Chan et al. 2012) . In obese subjects, upregulation of miR-200b correlated with a decreased expression of GATA2 as well as KDR, both of which play central roles in the angiogenic response and wound closure.
Previous studies in normal weight individuals with periodontitis reported increased expression of miRNAs linked to inflammatory/immune response pathways (Xie et al. 2011; Stoecklin-Wasmer et al. 2012) . In our study, none of these periodontitis-specific miRNAs were found differentially expressed among our samples, as all the study participants had periodontitis. This adds to the novelty of our findings, which describes the upregulation of miR-200b in the gingival tissue of obese periodontitis subjects.
Although the miRNA microarray allowed the analysis of a large number of miRNAs in parallel, the low sensitivity of the assay required more sensitive methods (qRT-PCR) to quantify the differences (Draghici et al. 2006) . Even though miR-200b expression reached statistical significance when measured by qRT-PCR, confirming the differences in other miRNAs (miR-557, miR-4721, and miR-196a) was challenging due to the small differences between the groups and the low expression levels, as previously noted (Fichtlscherer et al. 2010) . Further limitations of this study were the small sample size and tissue availability. We selected a limited number of miRNAs for qRT-PCR validation, using fold change and P value criteria. Our cutoff for microarray data comparisons between the 2 groups was set to 1.2-fold, which is in agreement with previous studies on miRNA expression suggesting that, unlike gene expression microarrays that use higher cutoff values, a smaller 1.2fold change in miRNA expression can be biologically relevant (Dalman et al. 2012; Pritchard et al. 2012 ). Furthermore, a more focused investigation in a larger sample set on the association of miR-557 and miR-4721 with obesity may be interesting, as they appeared decreased in the microarray in obese samples but significantly increased when measured by qRT-PCR.
To identify relevant miR-200b mRNA targets, we assumed that the gene targets of the primary transcript miR-200b are the same as the gene targets of miR-200b-5p. A search in TargetScan identified 1,057 transcripts with conserved sites as putative targets of human miR-200bc/429/548a. However, as the reliability of target predictions is still highly debatable (Pio et al. 2014) , we limited our functional analysis to "experimentally confirmed" miR-200b targets. This filtering might have excluded novel genes that could be regulated by miR-200b. Despite the smaller number of genes included, a substantial proportion of miR-200b genes were linked to biological pathways associated with miR-200b alone, such as cell migration and epithelium development. Comprehensive annotation of all the confirmed miR-200b target genes would aid the interpretation of this dataset.
The pathophysiologic mechanisms underlying periodontitis in the presence of obesity are complex and currently not fully understood. Here, we report that in obese patients with periodontitis gingival tissue, miR-200b is increased, suggesting a suppressing effect on a group of genes and transcription factors that may affect cell plasticity, tissue homeostasis, and angiogenesis. Addressing periodontitis with more effective treatments will reduce the risk of secondary events in remote tissues and organs, such as the cardiovascular system. Further extensive functional experiments in vitro and in animal models of periodontal disease are required to validate the suitability of the miR-200b regulatory network as a therapeutic target.
